https://slate.com/technology/2022/11/rsv-vaccine-surge-infants-fda.html
0
0
11/9/22 at 10:00am
Organization
Slate Magazine
Author
Niranjana Rajalakshmi
23 words
0
Comments
Pfizer will submit results of a phase 3 trial to the FDA soon.
You are the first to view
Create an account
or login to join the discussion